• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

BI-409306 Inhibitor

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5759307

BI-409306 is a potent and selective inhibitor of PDE9A (IC50 of 52nM), and can be used in the research of memory More details

Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
BI-409306, Inhibitor
Full Product Name
BI-409306
Product Gene Name
Form/Format
Solid. Powder
Purity/Purification
98.00%
Preparation and Storage
Store at -20 degree C for 3 years powder
-80 degree C for 2 years in solvent
Molecular Weight
311.34
Solubility
DMSO: 22mg/mL (50.06mM)
(<1mg/ml refers to the product slightly soluble or insoluble)
Formula
C16H17N5O2
SMILES
O=c1[nH]c(Cc2ccccn2)nc2n(ncc12)C1CCOCC1
CAS Number
1189767-28-9
Target & IC50
PDE9A: ic50 52nM
PDE1C: ic50 1uM
PDE1A: ic50 1.4uM

Product Categories/Family for BI-409306, inhibitor

Structure of BI-409306, inhibitor

BI-409306 Inhibitor – Cat# MBS5759307

Product References and Citations for BI-409306, inhibitor

Cornelia Dorner-Ciossek, R. Giovannini, Holger Rosenbrock. BI 409306, A NOVEL PHOSPHODIESTERASE 9A INHIBITOR, PART I: POTENCY, SELECTIVITY AND IN-VITRO FUNCTIONAL CHARACTERIZATION ON SYNAPTIC PLASTICITY[C]// International Congress on Schizophrenia Research. 2015.
Cornelia Dorner-Ciossek, R. Giovannini, Holger Rosenbrock. BI 409306, A NOVEL PHOSPHODIESTERASE 9A INHIBITOR, PART I: POTENCY, SELECTIVITY AND IN-VITRO FUNCTIONAL CHARACTERIZATION ON SYNAPTIC PLASTICITY[C]// International Congress on Schizophrenia Research. 2015.
Moschetti V, Kim M, Sand M, et al. The safety, tolerability and pharmacokinetics of BI 409306, a novel and potent PDE9 inhibitor: Overview of three Phase I randomised trials in healthy volunteers[J]. European Neuropsychopharmacology, 2018:S0924977X18300233.
Moschetti V, Kim M, Sand M, et al. The safety, tolerability and pharmacokinetics of BI 409306, a novel and potent PDE9 inhibitor: Overview of three Phase I randomised trials in healthy volunteers[J]. European Neuropsychopharmacology, 2018:S0924977X18300233.

Other Notes

Small volumes of BI-409306, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for BI-409306 purchase

MBS5759307 is an inhibitor targeting BI-409306.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000